Literature DB >> 35482891

Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial.

Navneet R Hakhu1,2, Daniel L Gillen1,2,3, Joshua D Grill4,5,2,3.   

Abstract

BACKGROUND: Dyadic enrollment of a participant and study partner is required in mild cognitive impairment (MCI) clinical trials, despite participants being functionally independent. Research examining how the study partner requirement impacts MCI trials remains limited.
METHODS: Using the Alzheimer's Disease Cooperative Study donepezil and vitamin E MCI trial data, we quantified the proportions of enrolled spouse, adult child, and other dyads. We used multinomial regression to identify which baseline participant characteristics (age, sex, race and ethnicity, apolipoprotein E ε4 status, education, residence type) were associated with dyad type.
RESULTS: Among 769 randomized dyads, 73% were spousal, 14% adult child, and 13% other dyads. Adjusting for multiple comparisons, underrepresented racial and ethnic background (eg, comparing Hispanic to non-Hispanic White participants: adult child vs. spouse odds ratio = 5.86; 95% confidence interval: 2.09, 16.5; other vs. spouse odds ratio = 4.95; 95% confidence interval: 1.83, 13.4), female sex, age, nonhouse residence, and apolipoprotein E ε4 noncarriage were each associated with a higher odds of having an adult child, as well as an other, study partner at enrollment. DISCUSSION: Increasing participation among nonspousal dyads may facilitate more inclusive and representative MCI trial samples.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35482891      PMCID: PMC9420751          DOI: 10.1097/WAD.0000000000000506

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.357


  37 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  Inclusion Across the Lifespan: NIH Policy for Clinical Research.

Authors:  Marie A Bernard; Janine A Clayton; Michael S Lauer
Journal:  JAMA       Date:  2018-10-16       Impact factor: 56.272

4.  Dyadic Analysis of Illness Perceptions Among Persons with Mild Cognitive Impairment and Their Family Members.

Authors:  Jennifer H Lingler; Lauren Terhorst; Richard Schulz; Amanda Gentry; Oscar Lopez
Journal:  Gerontologist       Date:  2015-04-15

5.  Race reporting and disparities in clinical trials on Alzheimer's disease: A systematic review.

Authors:  Marco Canevelli; Giuseppe Bruno; Giulia Grande; Federica Quarata; Riccardo Raganato; Francesca Remiddi; Martina Valletta; Valerio Zaccaria; Nicola Vanacore; Matteo Cesari
Journal:  Neurosci Biobehav Rev       Date:  2019-04-01       Impact factor: 8.989

6.  Differences in Alzheimer disease clinical trial outcomes based on age of the participants.

Authors:  Lon S Schneider; Richard E Kennedy; Guoqiao Wang; Gary R Cutter
Journal:  Neurology       Date:  2015-02-13       Impact factor: 9.910

7.  A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners.

Authors:  Chelsea G Cox; Mary M Ryan B A; Daniel L Gillen; Joshua D Grill
Journal:  Am J Geriatr Psychiatry       Date:  2018-11-03       Impact factor: 4.105

8.  Study partners: essential collaborators in discovering treatments for Alzheimer's disease.

Authors:  Emily A Largent; Jason Karlawish; Joshua D Grill
Journal:  Alzheimers Res Ther       Date:  2018-09-27       Impact factor: 6.982

9.  Comparative Effectiveness of Behavioral Interventions on Quality of Life for Older Adults With Mild Cognitive Impairment: A Randomized Clinical Trial.

Authors:  Melanie J Chandler; Dona E Locke; Julia E Crook; Julie A Fields; Colleen T Ball; Vaishali S Phatak; Pamela M Dean; Miranda Morris; Glenn E Smith
Journal:  JAMA Netw Open       Date:  2019-05-03

10.  Amyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study.

Authors:  Kacie D Deters; Valerio Napolioni; Reisa A Sperling; Michael D Greicius; Richard Mayeux; Timothy Hohman; Elizabeth C Mormino
Journal:  Neurology       Date:  2021-02-10       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.